Skip to main content
SpringerLink
Log in

Tachykarde Rhythmusstörungen

  • Chapter
Therapie innerer Krankheiten

Zusammenfassung

Eine Tachykardie ist definiert als eine Herzfrequenz von mehr als 1oo/min, unabhängig von der Ursache. Diese Tachykardie kann entstehen im Sinusknoten, im Vorhof, im AV-Überleitungsgewebe und in der Kammer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bethge K-P (1982) Langzeit-Elektrokardiographie. Springer, Berlin Heidelberg New York, S 57

    Book  Google Scholar 

  2. Bigger JT, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM, Multicenter postinfarction research group (1984) The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 69: 250

    Article  PubMed  Google Scholar 

  3. Blömer H, Wirtzfeld A, Delius W, Sebening H (1977) Das Sinusknoten-Syndrom. Perimed, Erlangen

    Google Scholar 

  4. Boineau JP, Cox JL (1982). Rationale for a direct surgical approach to control ventricular arrhythmias. Am J Cardiol 49:381

    Article  PubMed  CAS  Google Scholar 

  5. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators (1990) The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 323:1505

    Article  Google Scholar 

  6. Breithardt G, Seipel L, Haerten K, Abendroth PR, Loogen F (1979). Effektivitätskontrolle der antiarrhythmischen Therapie bei Patienten mit chronisch-rezidivierenden ventrikulären Tachykardien mittels elektrophysiologischer Stimulationsverfahren. Z Kardiol 68: 725

    PubMed  CAS  Google Scholar 

  7. Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D (1990) Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol 16:1711

    Article  PubMed  CAS  Google Scholar 

  8. Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989). Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Eng J Med 321: 406

    Article  Google Scholar 

  9. Ceremuzynski L, Kleczar E, Krzeminska-Pakula M, Kuch J, Nartowicz E, Smielak-Korombel J, Dyduszynski A, Maciejewicz J, Zaleska T, Lazarczyk-Kedzia E, Motyka J, Paczkowska B, Sczaniecka O, Yusuf S (1992) Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol 20:1056

    Article  PubMed  CAS  Google Scholar 

  10. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC (1990) Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. Circulation 82: 11106

    Article  Google Scholar 

  11. Ditchey RV, Karliner JS (1981) Safety of electrical cardioversion in patients without digitalis toxicity. Ann Int Med 95:676

    Article  PubMed  CAS  Google Scholar 

  12. Dreifus LS, Haiat R, Watanabe Y, Arriaga J, Rietman N (1971) A possible mechanism of sudden death in patients with WPW-syndrome. Circulation 43:520

    Article  PubMed  CAS  Google Scholar 

  13. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG on behalf of the Stroke Prevention in Atrial Fibrillation Investigators (1992) Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 20: 527

    Article  PubMed  CAS  Google Scholar 

  14. Gallagher JJ, Svenson RH, Kasell JH, German LD, Bardy GH, Broughton A, Critelli G (1982) Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med 306:194

    Article  PubMed  CAS  Google Scholar 

  15. Godtfredsen J (1982) Atrial fibrillation: course and prognosis — a follow-up study of 1212 cases. In: Kulbertus HE, Olsson SB, Schlepper M (eds) Atrial fibrillation. Astra, Mölndal/Sweden, p 134

    Google Scholar 

  16. Greene HL, Graham EL, Werner JA, Sears GK, Gross BW, Gorham JP, Kudenchuck PJ, Trobangh GB (1983) Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. JACC 2: 1114

    Article  PubMed  CAS  Google Scholar 

  17. Gulamhusein S, Ko P, Carruthers SG, Klein GJ (1982) Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil. Circulation 65:348

    Article  PubMed  CAS  Google Scholar 

  18. Hagemeijer F, Van Houwe E (1975) Titrated energy cardioversion of patients on digitalis. Br Heart J 37: 1303

    Article  PubMed  CAS  Google Scholar 

  19. Heger JJ, Prystowsky EN, Jackman WM, Naccarelli GV, Warfel KA, Rinkenberger RL, Zipes DP (1981) Amiodarone — clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med 305:539

    Article  PubMed  CAS  Google Scholar 

  20. Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL, Greenspan AM (1978) Recurrent sustained ventricular tachycardia. 2. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation 58:986

    Article  PubMed  CAS  Google Scholar 

  21. Jackman WM, Wang X, Friday KJ, Roman CA, Moulton KP, Beckman KJ, McClelland JH, Twidale N, Hazlitt HA, Prior MI, Morgolis PD, Calame JD, Overholt ED, Lazzara R (1991) Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med 324:1605

    Article  PubMed  CAS  Google Scholar 

  22. Jackman WM, Beckman KJ, McClelland JH et al. (1992) Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow pathway conduction. N Engl J Med 327:313

    Article  PubMed  CAS  Google Scholar 

  23. Jervell A, Lange-Nielsen F (1957) Congenital deaf-mutism, functional heart disease with prolongation of the QT-interval, and sudden death. Am Heart J 54:59

    Article  PubMed  CAS  Google Scholar 

  24. Kleiger R, Lown B (1966) Cardioversion and digitalis. II. Clinical studies. Circulation 33: 878

    Article  PubMed  CAS  Google Scholar 

  25. Koster RW, Dunning AJ (1985) Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction. N Engl J Med 313:1105

    Article  PubMed  CAS  Google Scholar 

  26. Lown B, Wolff M (1971) Approaches to sudden death from coronary heart disease. Circulation 44:130

    Article  PubMed  CAS  Google Scholar 

  27. Lown B, Wyatt NF, Levine HD (1960) Paroxysmal atrial tachycardia with block. Circulation 21: 129

    Article  PubMed  CAS  Google Scholar 

  28. Lüderitz B (1993) Therapie der Herzrhythmusstörungen. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  29. Mann DL, Maisel AS, Atwood EJ, Engler RJ, LeWinter MM (1985) Absence of cardioversion-induced ventricular arrhythmias in patients with therapeutic digoxin levels. JACC 5:882

    Article  PubMed  CAS  Google Scholar 

  30. Manz M, Steinbeck G, Gerckens U, Lüüderitz B (1985) Supraventrikuläre Tachykardie: Ergebnisse der His-Büündel-Ablation. Dtsch Med Wochenschr 1100:576

    Article  Google Scholar 

  31. Mason JW, for the Electrophysiologic Study Versus Electrocardiographic Monitoring Investigators (1993) A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic drug efficacy for ventricular tachyarrhythmias. N Engl J Med 329: 445

    Article  PubMed  CAS  Google Scholar 

  32. Mason JW, for the Electrophysiologic Study Versus Electrocardiographic Monitoring Investigators (1993) A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 329: 452

    Article  PubMed  CAS  Google Scholar 

  33. Mason JW, Winkle RA (1978) Electrode-catheter arrhythmia induction in the selction and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation 58: 971

    Article  PubMed  CAS  Google Scholar 

  34. Meinertz T, Hofmann T, Kasper W, Treese N, Bechtold H, Stienen U, Pop T, von Leitner ER, Andresen D, Meyer J (1984) Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 53:902

    Article  PubMed  CAS  Google Scholar 

  35. Mirowski M, Reid PR, Watkins L, Weisfeldt ML, Mower MM (1981) Clinical treatment of life-threatening ventricular tachyarrhythmias with the automatic implantable defibrillator. Am Heart J 102: 265

    Article  PubMed  CAS  Google Scholar 

  36. Mitchell LB, Duff HJ, Manyari DE, Wyse DG (1987) A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia. N Engl J Med 317:1681

    Article  PubMed  CAS  Google Scholar 

  37. Morady F, Sauve MJ, Malone P, Shen EN, scnwartz Bhzandari A, Keung E, Sung RJ, Scheinman MM (1983) Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. Am J Cardiol 52:975

    Article  PubMed  CAS  Google Scholar 

  38. Moss AJ, Davis HT, De Camilla J, Bayer LW (1979) Ventricular ectopic beats and their relation to sudden and non sudden cardiac death after myocardial infarction. Circulation 60:998

    Article  PubMed  CAS  Google Scholar 

  39. Multicenter Postinfarction Research Group (1983) Risk stratification and survival after myocardial infarction. N Engl J Med 309:331

    Article  Google Scholar 

  40. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B (1989) Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study. Lancet I:175

    Article  Google Scholar 

  41. Podrid PJ, Schoeneberger A, Lown B (1980) Congestive heart failure caused by oral disopyramide. N Engl J Med 302:614

    Article  PubMed  CAS  Google Scholar 

  42. Romano C, Gemme C, Pongiglione R (1963) Aritmie cardiache rare dell’età pediatrica. Clin Pediatr 45: 656

    CAS  Google Scholar 

  43. Ruskin JN, Mc Govern B, Garan H, DiMarco JP, Kelly E (1983) Antiarrhythmic drugs: a possible cause of out-ofhospital cardiac arrest. N Engl J Med 309:1302

    Article  PubMed  CAS  Google Scholar 

  44. Scheinman MM, Evans-Bell T (1984) Catheter ablation of the atrioventricular junction. A report of the percutaneous mapping and ablation registry. Circulation 70:1024

    Article  PubMed  CAS  Google Scholar 

  45. Scheinman MM, Morady F, Hess DS, Gonzalez R (1982) Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. J Am Med Assoc 248:851

    Article  CAS  Google Scholar 

  46. Schlepper M (1983) Spezielle Syndrome. In: Lüderitz B. (Hrsg) Handbuch der inneren Medizin. Bd IX/i: Herzrhythmusstörungen. Springer, Berlin Heidelberg New York Tokyo, S 643

    Google Scholar 

  47. Schmidt G, Ulm K, Barthel P, Riemenschneider A, Linzmaier A (1989) 3-D-Modell zur Validisierung antiarrhythmischer Effekte. In: Schlepper M (Hrsg) Neue und alte Behandlungsmöglichkeiten bei Herzrhythmusstörungen. Schattauer, Stuttgart New York, S 128

    Google Scholar 

  48. Sellers TD, Bashore TM, Gallagher JJ (1977) Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation. Circulation 56: 260

    Article  PubMed  Google Scholar 

  49. Steinbeck G (1983) Tachykarde Rhythmusstörungen. In: Lüüderitz B (Hrsg). Handbuch der inneren Medizin. Bd. IX/i: Herzrhythmusstörungen. Springer, Berlin Heidelberg New York Tokyo, S 617

    Google Scholar 

  50. Steinbeck G (1984) Die rhythmogene Herzinsuffizienz. In: Riecker G (Hrsg) Handbuch der inneren Medizin, Bd. IX/4: Herzinsuffizienz. Springer, Berlin Heidelberg New York Tokyo, S 461

    Google Scholar 

  51. Steinbeck G, Manz M, Lüderitz B (1981) Möglichkeiten und Risiken der programmierten Ventrikelstimulation bei Patienten mit chronisch rezidivierenden Kammertachykardien. Klin Wochenschr 59:111

    Article  PubMed  CAS  Google Scholar 

  52. Steinbeck G, Manz M, Lüüderitz B (1982) Amiodaron bei ventrikulären Tachykardien. MMW 124:723

    CAS  Google Scholar 

  53. Steinbeck G, Naumann d’Alnoncourt C, Lüderitz B (1983) Treatment of ventricular tachyarrhythmias-pacing: In: Steinbach K et al. (eds) Cardiac Pacing. Steinkopff, Darmstadt, p 779

    Chapter  Google Scholar 

  54. The Stroke Prevention in Atrial Fibrillation Investigators (1991) Stroke prevention in atrial fibrillation study: Final results. Circulation 84:527

    Article  Google Scholar 

  55. The Stroke Prevention in Atrial Fibrillation Investigators (1992) Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 116:1

    Article  Google Scholar 

  56. Tzivoni D, Banai S, Schuger C, Benhorin J, Keren A, Gottlieb S, Stern S (1988) Treatment of torsade de pointes with magnesium sulfate. Circulation 77:392

    Article  PubMed  CAS  Google Scholar 

  57. Vaughan-Williams EM (1970) Classification of antiarrhythmic drugs. In: Sandoe E, Flenstedt-Jensen E, Olesen KH (eds) Symposium on cardiac arrhythmias. Astra Södertälje/Sweden, p 449

    Google Scholar 

  58. Velebit V, Podrid P, Lown B, Cohen BH, Graboys TB (1982) Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 65: 886

    Article  PubMed  CAS  Google Scholar 

  59. Ward O (1964) A new familiar cardiac syndrome in children. J Ir Med Assoc 54: 103

    PubMed  CAS  Google Scholar 

  60. Wegscheider K, Andresen D, Leitner E-R von, Schröder R (1982) Neue Methode zur Erfassung der Spontanvariabilität einfacher und komplexer Rhythmusstörungen in Abhängigkeit von der Häufigkeit ihres Auftretens. Z Kardiol 71:179

    Google Scholar 

  61. Weirich J, Antoni H (1990) Differential analysis of the frequency-dependent effects of class i antiarrhythmic drugs according to periodical ligand binding: implications for antiarrhythmic and proarrhythmic efficacy. J Cardiovasc Pharmacol 15:998

    Article  PubMed  CAS  Google Scholar 

  62. Wolf PA, Dawber TR, Thomas HE, Kannel WB (1978) Epidemiologie assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. Neurology 28: 973

    Article  PubMed  CAS  Google Scholar 

  63. Zeiler Arnold A, Mick MJ, Mazurek RP, Loop FD, Trohman RG (1992) Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 19: 851

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. Steinbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik II, Klinikum Großhadern, Marchioninistraße 15, D-81377, München, Deutschland

    Gustav Paumgartner

  2. Kastanienallee 14, D-82049, Großhesselohe, Deutschland

    Gerhard Riecker

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Steinbeck, G. (1995). Tachykarde Rhythmusstörungen. In: Paumgartner, G., Riecker, G. (eds) Therapie innerer Krankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10479-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10479-8_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10480-4

  • Online ISBN: 978-3-662-10479-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation